Product Information

KETOROLAC 0.4% OPHTH SOLUTION is a generic product labeled by Pacific Pharma, Inc., priced at $12.7101 per ML under NDC 60758077305. Its NADAC has been published 650 times since Mar 12, 2014.

FDA first approved this application on May 30, 2003.

The High Outlier badge above means this manufacturer's average price in the Ketorolac Tromethamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

KETOROLAC 0.4% OPHTH SOLUTION

Ketorolac Tromethamine
$12.7101per ML
High Outlier

Strength

4 mg/mL

NDC

60758077305

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021528

FDA Approved

5/30/2003

On Market Since

11/21/2013

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 0.4% OPHTH SOLUTION has been published 650 times since Mar 12, 2014, and over the history we have for it it has risen 300.0%. The table below summarizes its recorded NADAC range and movement.

Current price$12.7101 per ML
All-time high$12.8326 (Feb 11, 2026)
All-time low$3.1773 (Mar 12, 2014)
52-week high$12.8326
52-week low$11.8362
Median price$9.6779
Average price$9.7130
Largest weekly change+89.8% (Apr 23, 2014)
Weeks tracked650
Tracking sinceMar 12, 2014

Price History

1W

-0.4%

1M

-0.4%

3M

-0.7%

6M

-0.3%

1Y

+7.4%

3Y

+33.1%

5Y

+31.9%

All

+300.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of KETOROLAC 0.4% OPHTH SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 0.4% OPHTH SOLUTION, manufactured by Pacific Pharma, Inc., is $12.7101 per ML (NDC 60758077305), effective Aug 19, 2026.

How has the price of KETOROLAC 0.4% OPHTH SOLUTION changed over time?

Over the history we have for it, the NADAC for KETOROLAC 0.4% OPHTH SOLUTION has risen 300.0%. It has been tracked across 650 weekly CMS publications since Mar 12, 2014.

What are the highest and lowest recorded NADAC prices for KETOROLAC 0.4% OPHTH SOLUTION?

Since Mar 12, 2014, the NADAC for KETOROLAC 0.4% OPHTH SOLUTION has ranged from a low of $3.1773 (Mar 12, 2014) to a high of $12.8326 (Feb 11, 2026), with a median of $9.6779 per ML.

Are there cheaper alternatives to KETOROLAC 0.4% OPHTH SOLUTION?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KETOROLAC 0.4% OPHTH SOLUTION in a comparable dosage form, but none are currently priced below it.

Who manufactures KETOROLAC 0.4% OPHTH SOLUTION?

KETOROLAC 0.4% OPHTH SOLUTION (NDC 60758077305) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.